NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MabPlex

MabPlex

Private
YantaiHealthcare & Life Scienceshttps://mabplexinc.com/

Last Round

Series B

Jun 8, 2020

Total Funding Raised

$129.8M

Company Overview

MabPlex is a biopharmaceutical company that provides comprehensive contract development and manufacturing services, ranging from drug development to the production of monoclonal antibodies, recombinant proteins, antibody-drug conjugates, and bispecifics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CDMOantibody-drug conjugatesADCbiologics manufacturingbioconjugationcontract manufacturingcGMP productioncell line developmentbioprocessingdrug developmentoutsourced pharmabiotech servicesclinical manufacturingprocess development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MabPlex Comparables

Compare MabPlex with similar companies based on industry and business-model similarity.

MabPlex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chime Biologics
88%
甲贝医药科技有限公司
86%
Canton Biologics
85%

MabPlex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 8, 2020
Series AJan 17, 2019

Key People

Founding team and executive leadership

Xinfang Li

Chief Executive Officer

Executive Team

MabPlex Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 8, 2020

    $71M round led by Huajin Capital.

MabPlex Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MabPlex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MabPlex's valuation, stock price, and market status.

Firmographic Details

HeadquartersYantai
Employee Range26
Year Founded2013
Last FundingJun 8, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.